RGBP
Price:
$0.0002
Market Cap:
$6.31K
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
Industry
Biotechnology
IPO Date
2014-10-06
Stock Exchange
OTC
Ticker
RGBP
According to Regen BioPharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 11.91%. This represents a change of 480.79% compared to the average of 2.05% of the last 4 quarters.
The mean historical ROE of Regen BioPharma, Inc. over the last ten years is 76.69%. The current 11.91% ROE has changed -84.47% with respect to the historical average. Over the past ten years (40 quarters), RGBP's ROE was at its highest in in the September 2016 quarter at 416.76%. The ROE was at its lowest in in the June 2022 quarter at -729.75%.
Average
76.69%
Median
22.17%
Minimum
-37.25%
Maximum
581.70%
Discovering the peaks and valleys of Regen BioPharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.77%
Maximum Annual ROE = 581.70%
Minimum Annual Increase = -254.90%
Minimum Annual ROE = -37.25%
| Year | ROE | Change |
|---|---|---|
| 2025 | 20.29% | 57.77% |
| 2024 | 12.86% | -164.10% |
| 2023 | -20.06% | -27.60% |
| 2022 | -27.71% | -155.24% |
| 2021 | 50.16% | -234.68% |
| 2020 | -37.25% | -254.90% |
| 2019 | 24.04% | -53.48% |
| 2018 | 51.69% | -53.51% |
| 2017 | 111.19% | -80.89% |
| 2016 | 581.70% | -74.43% |
The current ROE of Regen BioPharma, Inc. (RGBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.36%
5-year avg
7.11%
10-year avg
76.69%
Regen BioPharma, Inc.’s ROE is greater than Innovation Pharmaceuticals Inc. (-93.60%), greater than Viracta Therapeutics, Inc. (-128.57%), greater than Wesana Health Holdings Inc. (-506.80%), less than RespireRx Pharmaceuticals Inc. (19.21%), less than Actavia Life Sciences, Inc. (243.82%), less than Dental Patient Care America, Inc. (58.76%), less than ChitogenX Inc. (19.40%), greater than THC Farmaceuticals, Inc. (-0.33%), greater than Levitee Labs Inc. (-258.68%), less than Nascent Biotech, Inc. (268.93%),
| Company | ROE | Market cap |
|---|---|---|
| -93.60% | $103.67K | |
| -128.57% | $388.70K | |
| -506.80% | $341.00K | |
| 19.21% | $657.75K | |
| 243.82% | $385.91K | |
| 58.76% | $1.12M | |
| 19.40% | $627.63K | |
| -0.33% | $47.14K | |
| -258.68% | $369.15K | |
| 268.93% | $68.89K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regen BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Regen BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Regen BioPharma, Inc.'s ROE?
How is the ROE calculated for Regen BioPharma, Inc. (RGBP)?
What is the highest ROE for Regen BioPharma, Inc. (RGBP)?
What is the 3-year average ROE for Regen BioPharma, Inc. (RGBP)?
What is the 5-year average ROE for Regen BioPharma, Inc. (RGBP)?
How does the current ROE for Regen BioPharma, Inc. (RGBP) compare to its historical average?